New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
06:44 EDTPBYIPuma Biotechnology price target raised to $27 from $20 at Leerink
Leerink raised its price target for Puma Biotechnology citing the company's progress in advancing neratinib. The firm keeps an Outperform rating on the stock.
News For PBYI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
09:08 EDTPBYIPuma Biotechnology announces interim neratinib Phase II data
Subscribe for More Information
December 11, 2014
08:49 EDTPBYIPuma Biotechnology management to meet with UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use